Wim G Goettsch (Wim Goettsch)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Topics

Decision Making

Respiratory Syndrome Coronavirus

Clinical Evaluation

Top Venues

International journal of technology assessment in health care

BMJ (Clinical research ed.)

Journal of market access & health policy

This page only lists publications with an associated author ORCID identifier.

Publications

Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
High cost oncology drugs without proof of added benefit are burdening health systems. BMJ (Clinical research ed.) 384 (2024)
Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
High cost oncology drugs without proof of added benefit are burdening health systems. BMJ (Clinical research ed.) 384 (2024)
Nikki C C Werkman, Gema García-Sáez, Johannes T H Nielen, Jose Tapia-Galisteo, Francisco J Somolinos-Simón, M Elena Hernando, Junfeng Wang, Li Jiu, Wim G Goettsch, Carla J H van der Kallen, Annemarie Koster, Miranda T Schram, Hein de Vries, Nanne K de Vries, Simone J P M Eussen, Annemariek H M Driessen, Coen D A Stehouwer
Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study. Diabetologia 67 (4) (2024)
Nikki C C Werkman, Gema García-Sáez, Johannes T H Nielen, Jose Tapia-Galisteo, Francisco J Somolinos-Simón, M Elena Hernando, Junfeng Wang, Li Jiu, Wim G Goettsch, Carla J H van der Kallen, Annemarie Koster, Miranda T Schram, Hein de Vries, Nanne K de Vries, Simone J P M Eussen, Annemariek H M Driessen, Coen D A Stehouwer
Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study. Diabetologia 67 (4) (2024)
Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study. BMJ (Clinical research ed.) 384 (2024)
Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study. BMJ (Clinical research ed.) 384 (2024)
Nikki C C Werkman, Gema García-Sáez, Johannes T H Nielen, Jose Tapia-Galisteo, Francisco J Somolinos-Simón, M Elena Hernando, Junfeng Wang, Li Jiu, Wim G Goettsch, Carla J H van der Kallen, Annemarie Koster, Miranda T Schram, Hein de Vries, Nanne K de Vries, Simone J P M Eussen, Annemariek H M Driessen, Coen D A Stehouwer
Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study. Diabetologia 67 (4) (2024)
Nikki C C Werkman, Gema García-Sáez, Johannes T H Nielen, Jose Tapia-Galisteo, Francisco J Somolinos-Simón, M Elena Hernando, Junfeng Wang, Li Jiu, Wim G Goettsch, Carla J H van der Kallen, Annemarie Koster, Miranda T Schram, Hein de Vries, Nanne K de Vries, Simone J P M Eussen, Annemariek H M Driessen, Coen D A Stehouwer
Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study. Diabetologia (2024)
Thomas Desmet, Elaine Julian, Walter Van Dyck, Isabelle Huys, Steven R A Simoens, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter G M Mol, Anja Schiel, Wim G Goettsch, Hendrika van den Ham, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales, Jörg Ruof
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators. Journal of market access & health policy 12 (1) (2024)
Nikki C C Werkman, Gema García-Sáez, Johannes T H Nielen, Jose Tapia-Galisteo, Francisco J Somolinos-Simón, M Elena Hernando, Junfeng Wang, Li Jiu, Wim G Goettsch, Carla J H van der Kallen, Annemarie Koster, Miranda T Schram, Hein de Vries, Nanne K de Vries, Simone J P M Eussen, Annemariek H M Driessen, Coen D A Stehouwer
Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study. Diabetologia 67 (4) (2024)
Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study. BMJ (Clinical research ed.) 384 (2024)
Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
High cost oncology drugs without proof of added benefit are burdening health systems. BMJ (Clinical research ed.) 384 (2024)
Thomas Desmet, Elaine Julian, Walter Van Dyck, Isabelle Huys, Steven R A Simoens, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter G M Mol, Anja Schiel, Wim G Goettsch, Hendrika van den Ham, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales, Jörg Ruof
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators. Journal of market access & health policy 12 (1) (2024)
Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study. BMJ (Clinical research ed.) 384 (2024)
Milou Amber Hogervorst, Rick A Vreman, Inkatuuli Heikkinen, Indranil Bagchi, Iñaki Gutierrez-Ibarluzea, Bettina Ryll, Hans-Georg Eichler, Elena Petelos, Sean Tunis, Claudine Sapede, Wim G Goettsch, Rosanne Janssens, Isabelle Huys, Liese Barbier, Deirdre DeJean, Valentina Strammiello, Dimitra Lingri, Melinda Goodall, Magdalini Papadaki, Massoud Toussi, Despina Voulgaraki, Ania Mitan, Wija Oortwijn
UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP. International journal of technology assessment in health care (2023)
Jamie Elvidge, Ashley Summerfield, Saskia Knies, Bertalan Németh, Zoltán Kaló, Wim G Goettsch, Dalia M Dawoud, null null
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations. International journal of technology assessment in health care 39 (1) (2023)
Jamie Elvidge, Ashley Summerfield, Saskia Knies, Bertalan Németh, Zoltán Kaló, Wim G Goettsch, Dalia M Dawoud, null null
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations. International journal of technology assessment in health care 39 (1) (2023)
Bertalan Németh, Maria Kamusheva, Zornitsa Mitkova, Zsuzsanna Ida Petykó, Antal Tamás Zemplényi, Maria Dimitrova, Konstantin Tachkov, László Balkányi, Marcin Czech, Dalia M Dawoud, Wim G Goettsch, Rok Hren, Saskia Knies, László Lorenzovici, Zorana Maravic, Oresta Piniazhko, Spela Zerovnik, Zoltán Kaló
Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making. Journal of comparative effectiveness research (2023)
Jamie Elvidge, Ashley Summerfield, Saskia Knies, Bertalan Németh, Zoltán Kaló, Wim G Goettsch, Dalia M Dawoud, null null
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations. International journal of technology assessment in health care 39 (1) (2023)
Ting Wang, Neil McAuslane, Wim G Goettsch, Hubert G M Leufkens, Marie L De Bruin
Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement. International journal of technology assessment in health care 39 (1) (2023)
Jamie Elvidge, Ashley Summerfield, Saskia Knies, Bertalan Németh, Zoltán Kaló, Wim G Goettsch, Dalia M Dawoud, null null
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations. International journal of technology assessment in health care 39 (1) (2023)
Li Jiu, Milou A Hogervorst, Rick A Vreman, Aukje K Mantel-Teeuwisse, Wim G Goettsch
Understanding innovation of health technology assessment methods: the IHTAM framework. International journal of technology assessment in health care 38 (1) (2022)
Rick A Vreman, George Strigkos, Hubert G M Leufkens, Holger J Schünemann, Aukje K Mantel-Teeuwisse, Wim G Goettsch
Addressing uncertainty in relative effectiveness assessments by HTA organizations. International journal of technology assessment in health care 38 (1) (2022)
Rachel R J Kalf, Diana M J Delnoij, Bettina Ryll, M Marcel Bouvy, Wim G Goettsch
Information Patients With Melanoma Spontaneously Report About Health-Related Quality of Life on Web-Based Forums: Case Study. Journal of medical Internet research 23 (12) (2021)
Hans-Georg Eichler, Roisin Adams, Einar Andreassen, Peter Arlett, Marc van de Casteele, Suzannah J Chapman, Wim G Goettsch, Jonathan Lind Martinsson, Jordi Llinares-Garcia, Anna Nachtnebel, Elias Pean, Guido Rasi, Tove Ragna Reksten, Lonneke Timmers, Rick A Vreman, Inneke van de Vijver, Martin Wenzl
Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements. International journal of technology assessment in health care 37 (1) (2021)
Rachel R J Kalf, Marloes Zuidgeest, Diana M J Delnoij, Marcel L Bouvy, Wim G Goettsch
Bridging health technology assessment and healthcare quality improvement using international consortium of health outcomes measurement standard sets. International journal of technology assessment in health care 38 (1) (2021)
Rachel R J Kalf, Rick A Vreman, Diana M J Delnoij, M Marcel Bouvy, Wim G Goettsch
Bridging the gap: Can International Consortium of Health Outcomes Measurement standard sets align outcomes accepted for regulatory and health technology assessment decision-making of oncology medicines. Pharmacology research & perspectives 9 (2) (2021)
Bertalan Németh, Wim G Goettsch, Finn Børlum Kristensen, Oresta Piniazhko, Mirjana Huić, Tomáš Tesař, Dragana Atanasijevic, Iga Lipska, Zoltán Kaló
The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries. Expert review of pharmacoeconomics & outcomes research 20 (4) (2020)
Enver Kağan Atikeler, H G M Bert Leufkens, Wim G Goettsch
Access to medicines in Turkey: Evaluation of the process of medicines brought from abroad. International journal of technology assessment in health care 36 (6) (2020)
Rachel R J Kalf, Amr Makady, Renske M T Ten Ham, Kim Meijboom, Wim G Goettsch, null null
Use of Social Media in the Assessment of Relative Effectiveness: Explorative Review With Examples From Oncology. JMIR cancer 4 (1) (2018)